MedPath

Hill Dermaceuticals, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:2

Trial Phases

3 Phases

Phase 1:1
Phase 2:2
Phase 3:1

Drug Approvals

1

FDA:1

Drug Approvals

TOLAK

Approval Date
Sep 6, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
2 (50.0%)
Phase 1
1 (25.0%)
Phase 3
1 (25.0%)

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

Phase 3
Recruiting
Conditions
Otomycosis
Interventions
First Posted Date
2022-12-21
Last Posted Date
2024-01-17
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
100
Registration Number
NCT05660382
Locations
πŸ‡ΊπŸ‡Έ

Charleston ENT Associates, LLC, North Charleston, South Carolina, United States

πŸ‡ΊπŸ‡Έ

Head and Neck Surgery Specialist, Chula Vista, California, United States

πŸ‡ΊπŸ‡Έ

Advanced ENT & Allergy, Louisville, Kentucky, United States

and more 4 locations

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

Phase 2
Completed
Conditions
Otomycosis
Interventions
Drug: vehicle oil
First Posted Date
2020-06-16
Last Posted Date
2024-01-19
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
382
Registration Number
NCT04432376
Locations
πŸ‡ΊπŸ‡Έ

Head and Neck Surgery Specialists, Chula Vista, California, United States

πŸ‡ΊπŸ‡Έ

UCSD, La Jolla, California, United States

πŸ‡ΊπŸ‡Έ

DaVinci Research, LLC, Roseville, California, United States

and more 9 locations

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Phase 1
Terminated
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2019-02-20
Last Posted Date
2021-06-23
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
8
Registration Number
NCT03847389
Locations
πŸ‡ΊπŸ‡Έ

International Clinical Research - US, LLC, Sanford, Florida, United States

πŸ‡ΊπŸ‡Έ

AeroAllergy Research Laboratories of Savannah, Inc, Savannah, Georgia, United States

πŸ‡ΊπŸ‡Έ

Paddington Testing Co., Inc., Philadelphia, Pennsylvania, United States

and more 3 locations

Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

Phase 2
Completed
Conditions
Otomycosis
Interventions
Drug: 7-Day Miconazole Oil (Miconazole 2%)
Drug: 14-Day Miconazole Oil (Miconazole 2%)
Drug: 14-Day Placebo - Oil Vehicle
First Posted Date
2017-04-26
Last Posted Date
2022-10-05
Lead Sponsor
Hill Dermaceuticals, Inc.
Target Recruit Count
65
Registration Number
NCT03130738
Locations
πŸ‡ΊπŸ‡Έ

Head and Neck Surgery Specialist, Chula Vista, California, United States

πŸ‡ΊπŸ‡Έ

University of California San Diego, La Jolla, California, United States

πŸ‡ΊπŸ‡Έ

Ear Nose and Throat Associates of Southe Florida, Boynton Beach, Florida, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.